| abstract |
A novel use of a pyrimidine derivative containing an LRRK kinase inhibitor as an active ingredient, the pharmaceutical composition for preventing or treating at least one cancer selected from the group consisting of pancreatic cancer, breast cancer and lung cancer provided in one aspect of the present invention. Since it shows excellent cancer treatment effect in vitro and in vivo, it can be usefully used as a therapeutic agent for pancreatic cancer, breast cancer and lung cancer. |